LRG1 and colorectal carcinoma: To evaluate the relevance between LRG1 and clinical outcome, we examined LRG1 expression by immunohistochemistry (IHC) in the tissue microarray (TMA) which consists of tumor specimens of 141 stage I-stage IV CRC patients with up to 5 years of follow-up information.